The inflammatory bowel diseases, Crohn's disease and ulcerative colitis, are chronic frequently disabling inflammatory disorders of the small and large intestines. Despite extensive immunologic, pathologic and microbiologic reseerch, the etiology remains unknown, and the pathophysiology is poorly understood. Medical therapy is suboptimal and often associated with considerable morbidity. The risk of colorectal cancer is significantly increased for both disorders. There is strong evidence from twin studies, studies of familial aggregation and ethnic differences in disese prevalence that the inflammatory bowel diseases (IBD), Crohn's disease (CD) and ulcerative colitis (UC), are in large part genetic. The disorders are categorized as complex genetic disorders, since inheritance does not follow simple Mendelian patterns. In comparison with other complex genetic disorders the degree of genetic clustering in siblings, expressed as ns and defined as the increased risk over population prevalence for a sibling of a proband, is relatively large. ns for CD, UC and IBD have been estimated at 36.5, 16.6 and 24.7, respectively, comparatively greater than that for other disorders where susceptibility genes have been better established, such as IDDM and schizophrenia where ns is 15 and 8.6, respectively. CD and UC are genetically related as the cross disease relative risk is 3.85 with a CD proband and 1.72 with a UC proband. Our genetic studies on IBD are based on the hypothesis that there are specific susceptibility genes which are responsible for the familial clustering of these diseases. Susceptibility gene identification will allow an understanding of the initial pathophysiologic mechanisrns, and thus make it possible to design better medical therapy and better predict the disease course.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Salemi, Parissa; Skalamera Olson, Julie M; Dickson, Lauren E et al. (2018) Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI. J Clin Endocrinol Metab 103:158-168
Robert Braši?, James; Mari, Zoltan; Lerner, Alicja et al. (2018) Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration. Int J Phys Med Rehabil 6:
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866
AIDS-defining Cancer Project Working Group of IeDEA, COHERE in EuroCoord (2018) Non-Hodgkin lymphoma risk in adults living with HIV across five continents. AIDS 32:2777-2786
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Elion, Richard A; Althoff, Keri N; Zhang, Jinbing et al. (2018) Recent Abacavir Use Increases Risk of Type 1 and Type 2 Myocardial Infarctions Among Adults With HIV. J Acquir Immune Defic Syndr 78:62-72
Al-Sofiani, Mohammed E; Yanek, Lisa R; Faraday, Nauder et al. (2018) Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab 103:4599-4608
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451

Showing the most recent 10 out of 1014 publications